Annual SG&A
$8.10B$411.00M-4.83%
Summary
- Current Value
- As of today, MCK annual SG&A is $8.10B, down -4.83% on
- Historical Performance
- MCK annual SG&A is up +4.12% over the past 3 years, down -8.51% over the past 5 years
- All-Time High Comparison
- MCK annual SG&A is currently -23.17% below its historical high of $10.54B set on
- 3-Year Low Comparison
- MCK annual SG&A is +4.12% above its 3-year low of $7.78B reached on an earlier date
- Sector Comparison
- MCK annual SG&A is higher than 99.91% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $8.10B | -4.8% | +4.1% | -8.5% | +129.4% | |
| Quarterly SG&A | $2.26B | +3.1% | +21.1% | +1.4% | +118.3% | |
| TTM SG&A | $85.43B | +881.7% | +1011.4% | +850.9% | +2006.8% | |
| Price | $879.87 | +30.8% | +99.9% | +345.9% | +1011.0% | |
| Annual Operating Expenses | $8.10B | -0.1% | +9.3% | +0.4% | +108.1% | |
| Annual Operating Profit | $5.95B | +36.1% | +33.6% | +69.5% | +183.7% | |
| Annual D&A | $729.00M | +14.6% | -14.9% | -40.3% | +47.0% | |
| Annual Revenue | $403.43B | +12.4% | +45.8% | +69.3% | +259.9% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.66B | -6.5% | |
| 5Y | $10.54B | -23.2% | |
| All | $10.54B | -23.2% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.78B | N/A | +4.1% |
| 5Y | $7.78B | +4.1% | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of MCK?
- As of today, MCK annual SG&A is $8.10B
- What is 1-year change in MCK annual SG&A?
- MCK annual SG&A is down -4.83% year-over-year
- What is 3-year change in MCK annual SG&A?
- MCK annual SG&A is up +4.12% over the past 3 years
- How far is MCK annual SG&A from its all-time high?
- MCK annual SG&A is currently -23.17% below its historical high of $10.54B set on March 31, 2022
- How does MCK annual SG&A rank versus sector peers?
- MCK annual SG&A is higher than 99.91% of companies in Healthcare sector
- When is MCK next annual earnings release?
- As of today, the next annual earnings release for MCK has not been scheduled
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$2.26B$468.00M+26.06%
Summary
- Current Value
- As of today, MCK quarterly SG&A is $2.26B, up +26.06% on
- Historical Performance
- MCK quarterly SG&A is up +3.10% year-over-year, up +21.07% over the past 3 years
- All-Time High Comparison
- MCK quarterly SG&A is currently -27.09% below its historical high of $3.11B set on
- 3-Year Low Comparison
- MCK quarterly SG&A is +26.06% above its 3-year low of $1.80B reached on
- Sector Comparison
- MCK quarterly SG&A is higher than 98.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $2.26B | +26.1% | +3.1% | +21.1% | +1.4% | |
| Annual SG&A | $8.10B | – | -4.8% | +4.1% | -8.5% | |
| TTM SG&A | $85.43B | +955.2% | +881.7% | +1011.4% | +850.9% | |
| Price | $879.87 | +21.3% | +30.8% | +99.9% | +345.9% | |
| Quarterly Operating Expenses | $2.07B | +29.3% | +1.8% | +16.6% | -1.2% | |
| Quarterly Operating Profit | $1.42B | -36.8% | +32.2% | +37.4% | +77.6% | |
| Quarterly D&A | $195.00M | -0.5% | +24.2% | -10.1% | -36.7% | |
| Quarterly Revenue | $105.38B | +9.4% | +7.7% | +41.5% | +68.1% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.26B | at high | |
| 3Y | $2.51B | -9.7% | |
| 5Y | $3.11B | -27.1% | |
| All | $3.11B | -27.1% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.80B | +26.1% | |
| 3Y | $1.80B | +26.1% | |
| 5Y | $1.80B | +26.1% | |
| All | -$79.90M | +2933.5% |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of MCK?
- As of today, MCK quarterly SG&A is $2.26B
- What is MCK quarterly SG&A most recent change?
- MCK quarterly SG&A was up +26.06% on June 30, 2026
- What is 1-year change in MCK quarterly SG&A?
- MCK quarterly SG&A is up +3.10% year-over-year
- How far is MCK quarterly SG&A from its all-time high?
- MCK quarterly SG&A is currently -27.09% below its historical high of $3.11B set on December 31, 2021
- How does MCK quarterly SG&A rank versus sector peers?
- MCK quarterly SG&A is higher than 98.80% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$85.43B$4.19B+5.16%
Summary
- Current Value
- As of today, MCK TTM SG&A is $85.43B, up +5.16% on
- Historical Performance
- MCK TTM SG&A is up +881.74% year-over-year, up +1011.37% over the past 3 years
- All-Time High Comparison
- MCK TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- MCK TTM SG&A is +79.33% above its 3-year low of $47.64B reached on an earlier date
- Sector Comparison
- MCK TTM SG&A is higher than 98.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $85.43B | +955.2% | +881.7% | +1011.4% | +850.9% | |
| Annual SG&A | $8.10B | – | -4.8% | +4.1% | -8.5% | |
| Quarterly SG&A | $2.26B | +26.1% | +3.1% | +21.1% | +1.4% | |
| Price | $879.87 | +21.3% | +30.8% | +99.9% | +345.9% | |
| TTM Operating Profit | $6.71B | +5.4% | +62.1% | +51.8% | +86.2% | |
| TTM D&A | $767.00M | +5.2% | +22.9% | -11.1% | -37.6% | |
| TTM Revenue | $410.98B | +1.9% | +8.8% | +44.7% | +67.6% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $85.43B | N/A | at high |
| 3Y | $85.43B | N/A | at high |
| 5Y | $85.43B | N/A | at high |
| All | $85.43B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $69.25B | N/A | +23.4% |
| 3Y | $47.64B | N/A | +79.3% |
| 5Y | $33.23B | N/A | +157.1% |
| All | $862.10M | N/A | +9809.6% |
TTM SG&A History
FAQ
- What is the current TTM SG&A of MCK?
- As of today, MCK TTM SG&A is $85.43B
- What is MCK TTM SG&A most recent change?
- MCK TTM SG&A was up +5.16% on June 30, 2026
- What is 1-year change in MCK TTM SG&A?
- MCK TTM SG&A is up +881.74% year-over-year
- How far is MCK TTM SG&A from its all-time high?
- MCK TTM SG&A is currently at its all-time high
- How does MCK TTM SG&A rank versus sector peers?
- MCK TTM SG&A is higher than 98.74% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- MCK Official Website www.mckesson.com
- MCK Profile on Yahoo Finance finance.yahoo.com/quote/MCK
- MCK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mck
